Patent 9895357 was granted and assigned to Nusirt Sciences Inc on February, 2018 by the United States Patent and Trademark Office.
Compositions, methods, and kits useful for treating hyperlipidemic conditions are provided herein. Such compositions can contain synergizing amounts of nicotinic acid, nicotinamide riboside and/or nicotinic acid metabolites in combination with leucine and/or a leucine metabolite, with or without resveratrol.